188 related articles for article (PubMed ID: 29733168)
1. [A comparative characteristic of antigenic properties of recombinant and native hbs-antigens with G145R mutation and evaluation of their immunogenicity].
Konopleva MV; Borisova VN; Sokolova MV; Feldsherova AA; Krymskij MA; Semenenko TA; Suslov AP
Vopr Virusol; 2017; 62(4):179-186. PubMed ID: 29733168
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations.
Cooreman MP; van Roosmalen MH; te Morsche R; Sünnen CM; de Ven EM; Jansen JB; Tytgat GN; de Wit PL; Paulij WP
Hepatology; 1999 Nov; 30(5):1287-92. PubMed ID: 10534351
[TBL] [Abstract][Full Text] [Related]
3. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity.
Zheng X; Weinberger KM; Gehrke R; Isogawa M; Hilken G; Kemper T; Xu Y; Yang D; Jilg W; Roggendorf M; Lu M
Virology; 2004 Nov; 329(2):454-64. PubMed ID: 15518823
[TBL] [Abstract][Full Text] [Related]
4. Antigenic and immunogenic changes due to mutation of s gene of HBV.
Ge JH; Liu HM; Sun J; Zhang LZ; He J; Li YL; Liu H; Xu Y; Yu HY; Hu YP
World J Gastroenterol; 2004 Nov; 10(21):3137-40. PubMed ID: 15457559
[TBL] [Abstract][Full Text] [Related]
5. Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg.
Heijtink RA; van Bergen P; van Roosmalen MH; Sünnen CM; Paulij WP; Schalm SW; Osterhaus AD
Vaccine; 2001 Jun; 19(27):3671-80. PubMed ID: 11395201
[TBL] [Abstract][Full Text] [Related]
6. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
Cooreman MP; Leroux-Roels G; Paulij WP
J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and viral quasispecies characteristics associated with infection by the hepatitis B virus G145R immune escape mutant.
Xue Y; Wang MJ; Yang ZT; Yu DM; Han Y; Huang D; Zhang DH; Zhang XX
Emerg Microbes Infect; 2017 Mar; 6(3):e15. PubMed ID: 28325923
[TBL] [Abstract][Full Text] [Related]
8. Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance.
Wu C; Deng W; Deng L; Cao L; Qin B; Li S; Wang Y; Pei R; Yang D; Lu M; Chen X
J Virol; 2012 Apr; 86(8):4658-69. PubMed ID: 22301154
[TBL] [Abstract][Full Text] [Related]
9. Construction and expression of hepatitis B surface antigen escape variants within the "a" determinant by site directed mutagenesis.
Golsaz Shirazi F; Amiri MM; Mohammadi H; Bayat AA; Roohi A; Khoshnoodi J; Zarnani AH; Jeddi-Tehrani M; Kardar GA; Shokri F
Iran J Immunol; 2013 Sep; 10(3):127-38. PubMed ID: 24076590
[TBL] [Abstract][Full Text] [Related]
10. Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity.
Hossain MG; Ueda K
PLoS One; 2017; 12(1):e0167871. PubMed ID: 28045894
[TBL] [Abstract][Full Text] [Related]
11. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication.
Wu C; Zhang X; Tian Y; Song J; Yang D; Roggendorf M; Lu M; Chen X
J Gen Virol; 2010 Feb; 91(Pt 2):483-92. PubMed ID: 19812261
[TBL] [Abstract][Full Text] [Related]
12. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
Tabor E
J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific "a" determinant conformation change and its application in diagnostic assays.
Kfoury Baz EM; Zheng J; Mazuruk K; Van Le A; Peterson DL
Transfus Med; 2001 Oct; 11(5):355-62. PubMed ID: 11696228
[TBL] [Abstract][Full Text] [Related]
14. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
Wu L; He JW; Yao X; Li HM; Wen YM
J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of anti HBs monoclonal antibody and its combination characterization to both wild-type HBsAg and immune escape mutant HBsAg].
Li FH; Zhang XY; Yan B; Zhang B; Huang YG; Zhang CY; Gong JS; Chen Y; Liu JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):594-6. PubMed ID: 18538091
[TBL] [Abstract][Full Text] [Related]
16. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection.
El Chaar M; Candotti D; Crowther RA; Allain JP
Hepatology; 2010 Nov; 52(5):1600-10. PubMed ID: 20815025
[TBL] [Abstract][Full Text] [Related]
17. Intra-familial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145R.
Oon CJ; Chen WN; Goo KS; Goh KT
J Infect; 2000 Nov; 41(3):260-4. PubMed ID: 11120616
[TBL] [Abstract][Full Text] [Related]
18. A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene.
Chen HB; Fang DX; Li FQ; Jing HY; Tan WG; Li SQ
World J Gastroenterol; 2003 Feb; 9(2):304-8. PubMed ID: 12532454
[TBL] [Abstract][Full Text] [Related]
19. Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis.
Rezaee R; Poorebrahim M; Najafi S; Sadeghi S; Pourdast A; Alavian SM; Alavian SE; Poortahmasebi V
Hepat Mon; 2016 Jul; 16(7):e39097. PubMed ID: 27642350
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B vaccination.
Romanò L; Paladini S; Galli C; Raimondo G; Pollicino T; Zanetti AR
Hum Vaccin Immunother; 2015; 11(1):53-7. PubMed ID: 25483515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
